(Add your underperform vote.). This book outlines the source and nature of uncertainty, discusses techniques for obtaining and using expert judgment, and reviews a variety of simple and advanced methods for analyzing uncertainty. Latest Share Price and Events Stable Share Price : BDSI is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week. Vote Outperform if you believe BDSI will outperform the S&P 500 over the long term. BioDelivery Sciences started at buy with $7 stock price target at SunTrust RH Mar. View BioDelivery Sciences International's earnings history. The company issued revenue guidance of $170 million-$180 million, compared to the consensus revenue estimate of $175.92 million. 6.409 USD . Learn about financial terms, types of investments, trading strategies and more. BioDelivery Sciences International (BDSI) is a Top-Ranked Momentum Stock: Should You Buy? Receive a free world-class investing education from MarketBeat. ), BioDelivery Sciences International has received 177 underperform votes. BDSI forecast,
BioDelivery Sciences International issued an update on its FY 2021 earnings guidance on Wednesday, August, 25th. Whether youre looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The average price target represents a 56.67% upside from the last price of $3.75. The P/E ratio of BioDelivery Sciences International is 12.33, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.69. What is BDSI's forecast return on assets (ROA) for 2021-2024? BioDelivery Sciences International does not have a long track record of dividend growth. All rights reserved. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Biodelivery Sciences International (BDSI). Yes. Their forecasts range from $6.00 to $6.25. Company Releases for BioDelivery Sciences International Inc. Tuesday, August 31, 2021. Best Biodelivery Sciences International forecast,
Among Growth Leaders In Subprime Lending Industry, Early stumble as El Salvador starts Bitcoin as currency, Stocks moderately lower as Wall Street returns from holiday, 4 vaccinated front-line workers cope with pandemic's toll, Protests disrupt autobahn traffic before German auto show, 3 Summer Stock Winners to (Hay)Ride This Fall, Golden Nugget Online Gaming Stock Blast Off Continues, Affirm Stock is Ready for the Next Leg Higher, Getting Ready to Retire? 4.055
Found insideStories like these are impressed upon the memory and their reading is productive only of good.". Tom Swift is the young protagonist in this series of juvenile adventure novels which began in the. View Biodelivery Sciences International, Inc. BDSI investment & stock information. BioDelivery Sciences will host a conference call and webcast today, August 5, 2020, at 8:30 a.m. The BioDelivery Sciences International stock price fell by -1.30% on the last day (Friday, 3rd Sep 2021) from $3.86 to $3.81. Vote Underperform if you believe BDSI will underperform the S&P 500 over the long term. BDSI Stock Analysis Overview. Ms. Coelho replaced Ernest De Paolantonio in these positions effective as of January 15, 2019. Not sure if you have heard?Blackbird PLC#BIRD #BELIKEBIRD $BIRD $BBRDF #BBRDFhttps://youtu.be/9AZA6fREkoA?t=2. Earnings for BioDelivery Sciences International are expected to grow by 70.37% in the coming year, from $0.27 to $0.46 per share. You may vote once every thirty days. Not within a year. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. In the past three months, BioDelivery Sciences International insiders have not sold or bought any company stock. There are currently 2 buy ratings for the stock. Biodelivery Sciences International Stock Price Forecast, "BDSI" Predictons for2021 abhijeet-shukla
expected to be around +58.05%. BioDelivery Sciences International does not currently pay a dividend. Biodelivery Sciences International quote is equal to 3.830 USD at 2021-08-29. Found insidePublished in 1971: At first glance it might seem that the three subjects dealt with in the essays written over the last twenty years and now collected in this volume could hardly be more diverse, beginning with the growth of the firm and 09:40 AM ET. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. BDSI stock future price,
BDSI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Goldman Sachs Group Inc., Blair William & Co. IL, Vanguard Group Inc., Wells Fargo & Company MN, Nuveen Asset Management LLC, Algert Global LLC, and Bank of America Corp DE. Biodelivery Sciences International finance tips,
Wall Street analysts have given BioDelivery Sciences International a "Buy" rating, but there may be better buying opportunities in the stock market.
This handbook is addressed toward patent attorneys and attorneys-at-law specializing in patent law, especially in Europe, but essentially worldwide. [Subject: European Law, German Law, Patent Law, Pharmaceutical Law] BioDelivery Sciences International's stock is owned by a variety of institutional and retail investors. Analysts covering this company mostly recommend stock overweighting or purchase. Download your FREE Technical Analysis Trading Guide Today! The book includes four appendices. The first introduces basic concepts in statistics and financial time series referred to throughout the book. Is Biodelivery Sciences International a profitable investment? Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Predictions on business development from analysts polled by Standard & Poor's are tight. View our earnings forecast for BioDelivery Sciences International. Given the current short-term trend, the stock is expected to rise 2.3% during About the BioDelivery Sciences International, Inc. stock forecast As of 2021 August 24, Tuesday current price of BDSI stock is 3.700$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Short-term and long-term BDSI (Biodelivery Sciences International)
BioDelivery Sciences International, Inc. is followed by the analysts listed above. On average, Wall Street analysts predict that. The specialty pharmaceutical company reported $0.09 EPS for the quarter, topping the Zacks' consensus estimate of $0.05 by $0.04. MarketBeat thinks these five companies may be even better buys.View MarketBeat's top stock picks here. Export data to Excel for your own analysis. Get short term trading ideas from the MarketBeat Idea Engine. 4.395 USD in
With a one year PEG ratio of 3.89, Biodelivery Sciences International Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 14.62% of US stocks. BioDelivery Sciences International's mailing address is 4131 PARKLAKE AVENUE SUITE 225, RALEIGH NC, 27612. Mr. BDSI Stock Summary. This is my medicine! Chelsea Leyland, founder, model, DJ, and activist A highly educational and relevant work thats both engaging and easy to follow. Kirkus Reviews "Fully living up to the promise of its title, Reader's View our full suite of financial calendars and market data tables, all for free. Meanwhile, the rest of the market is forecast to only expand by 12% per year, which is noticeably less attractive. This volume examines: Different perspectives on the role of government, including market based health care reforms and competition in the financing and delivery of health care Emerging trends recent reforms and social issues Keys issues in With this information, we find it odd that BioDelivery Sciences International is trading at a P/E lower than the market. Historical
Below you will find the price predictions for 2021, 2022, 2023, 2024, 2025, 2026. BioDelivery Sciences International has a P/B Ratio of 3.80. Found inside Page iiThis book shows us how we can use the cutting-edge knowledge about agriculture, nanotechnology, and biotechnology to increase the agricultural productivity and shape a sustainable future in order to increase the social welfare in rural This book also explores the potential effects on the environment, ecosystems and consumers and addresses the implications of intellectual property for nanobiopesticides. Read more Please log in to your account or sign up in order to add this asset to your watchlist. Please note that any opinions, estimates or forecasts regarding BioDelivery Sciences International, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of BioDelivery Sciences International, Inc. or its management. The high price target Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. What is BDSI's earnings growth forecast for 2021-2023? Read more RALEIGH, N.C. , Sept. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey , Chief Executive Officer, and. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Based on our forecasts, a long-term increase is expected, the "BDSI" stock price prognosis for 2026-08-24 is 6.383 USD. America is in the middle of an epidemic it has never seen before. The opioid crisis knows no bounds. It is affecting individuals and families in every congressional district. Question Box:
Since then, BDSI stock has increased by 2.8% and is now trading at $4.07. BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally. BDSI prediction,
When will BDSI price fall? When will BDSI stock price go down? WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) posted its earnings results on Tuesday, August, 3rd. BioDelivery Sciences (BDSI) - Long - 100 Percent Gain Potential. kettererfam_7717
The official website for BioDelivery Sciences International is www.bdsi.com. BioDelivery Sciences International has received 75.42% outperform votes from our community. This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines.
The symposium on supportive care in cancer patients, which took place in St. Gallen, Switzerland, on February 18-21, 1987, wel comed renowned experts in the field and more than 600 partici pants from 25 countries with the aim of stimulating How will Biodelivery Sciences International stock price increase? Compare Top Brokerages Here. Biodelivery Sciences International market prognosis,
BDSI stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Systematic Financial Management LP, State Street Corp, Dimensional Fund Advisors LP, American Century Companies Inc., GSA Capital Partners LLP, Panagora Asset Management Inc., and Dupont Capital Management Corp. View insider buying and selling activity for BioDelivery Sciences International or or view top insider-buying stocks. Since then, BDSI shares have decreased by 3.3% and is now trading at $3.83. Biodelivery Sciences International. Shares of BDSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is BioDelivery Sciences International's stock price today? The compound provides pain relief and has a relatively low risk for developing dependence, which is in demand given the opioid crisis in the United States, which demands less-addictive pain management solutions. Biodelivery Sciences BDSI Pivot Points Stock Traders Daily. Fundamental company data provided by Zacks Investment Research. Written by a team of expert academics and clinicians from a range of health backgrounds, the text uses a problem-solving approach, breaking down difficult A&P concepts through case studies, multiple-choice questions, images, feature boxes View analysts' price targets for BioDelivery Sciences International or view top-rated stocks among Wall Street analysts. BioDelivery Sciences International Inc (BDSI:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. With a 5-year investment, the revenue is expected to be around +66.66%. 12:48 PM ET. What this means: Biodelivery Sci Intl (BDSI) gets an Overall Rank of 53, which is an above average rank under InvestorsObserver's stock ranking system. BioDelivery Sciences International was founded in 1997. Ms. Coelho will also serve as the Companys principal financial officer and principal accounting officer. in one year. The BDSI ("BDSI" )
View all of BDSI's competitors. MarketBeat's community ratings are surveys of what our community members think about BioDelivery Sciences International and other stocks. BDSI stock price prediction,
Will BDSI price drop? BioDelivery Sciences International had a net margin of 20.65% and a trailing twelve-month return on equity of 31.75%. The 12-month stock price forecast is 6.88, which is an increase of 94.35% from the latest price. The current price level -23.05% lower than the highest price of $4.99 marked by the stock while trading over the past 52-weeks, whereas it is 26.32% higher than the lowest price of $3.04 the company dropped to over past 52-weeks. According to 7 analysts, the average rating for BDSI stock is "Strong Buy." MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. BioDelivery Sciences International's stock was trading at $3.96 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. When will Biodelivery Sciences International price drop? Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. It is focused on pain management, and its flagship product is BELBUCA. On average, Wall Street analysts predict that . The specialty pharmaceutical company earns $25.71 million in net income (profit) each year or $0.24 on an earnings per share basis. With a 5-year investment, the revenue is
4.055 USD to
View institutional ownership trends for BioDelivery Sciences International. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Only 9.98% of the stock of BioDelivery Sciences International is held by insiders. CFO, Treasurer & Executive Vice President, Start Your Risk-Free Trial Subscription Here, Abbott Labs Breaks Out Of Six-Month Base In Low Turnover, Credit Acceptance Corp. This book is a study of earnings management, aimed at scholars and professionals in accounting, finance, economics, and law. Will BDSI stock price rise? A New Way To "Inflation Proof" Your Wealth, When inflation hits an all time high, most investors see gold as a safe haven. Yes. The specialty pharmaceutical company can be reached via phone at (919) 582-9050 or via email at [emailprotected]. View which stocks are hot on social media with MarketBeat's trending stocks report. This concise, practical book sets out to bring physicians and medical practitioners up to date with advances in the management of acute and chronic pain. Is Biodelivery Sciences International Stock a good buy in 2021, according to Wall Street analysts? The company provided EPS guidance of for the period. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. BioDelivery Sciences International has a market capitalization of $401.30 million and generates $156.47 million in revenue each year. Find the latest analyst research for BioDelivery Sciences International Forecast Changes; Commodities. Your current $100 investment may be up to $166.66 in 2026. What is BDSI's forecast return on equity (ROE) for 2021-2024? Based on our forecasts, a long-term increase is expected,
Sign-up to receive the latest news and ratings for BioDelivery Sciences International and its competitors with MarketBeat's FREE daily newsletter. USD today. Biodelivery Sciences International quote is equal to 4.055 USD at 2021-09-08. View insider buying and selling activity for BioDelivery Sciences International or view top insider-selling stocks. The consensus among Wall Street equities research analysts is that investors should "buy" BioDelivery Sciences International stock. To see all exchange delays and terms of use please see disclaimer. This price target is based on 2 analysts offering 12 month price targets for BioDelivery Sciences International in the last 3 months. In 2023, BDSI is forecast to generate $76,906,086 in earnings, with the lowest earnings forecast at $64,088,405 and the highest earnings forecast at $89,723,767. 09:00 AM ET BioDelivery Sciences International's stock was trading at $3.96 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BDSI shares have decreased by 8.3% and is now trading at $3.63. Get daily stock ideas top-performing Wall Street analysts. (Add your outperform vote. Find the latest Earnings Report Date for BioDelivery Sciences International, Inc. Common Stock Yearly Earnings Forecast basis and include stock option expenses where possible. According to analysts' consensus price target of $6.13, BioDelivery Sciences International has a forecasted upside of 50.5% from its current price of $4.07. BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. On average, they anticipate BioDelivery Sciences International's share price to reach $6.13 in the next twelve months. Their average twelve-month price target is $6.13, predicting that the stock has a possible upside of 58.68%. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Some companies that are related to BioDelivery Sciences International include Johnson & Johnson (JNJ), Pfizer (PFE), Eli Lilly and (LLY), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Pacira BioSciences (PCRX), Corcept Therapeutics (CORT) and Supernus Pharmaceuticals (SUPN). This suggests a possible upside of 50.5% from the stock's current price. Adding BioDelivery Sciences International, Inc. High institutional ownership can be a signal of strong market trust in this company. BioDelivery Sciences International's stock was trading at $3.96 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. BioDelivery Sciences to Report Second Quarter 2021 Financial Results on August 4, 2021. Presents guidelines on how to invest successfully by becoming a "prudent speculator," explaining the role of psychology in risk taking while covering such topics as spotting an undervalued stock and knowing when to sell. Find the latest BioDelivery Sciences Internatio BDSI analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. You'll discover his top three "Extreme Dividend" stocks that could supercharge your dividends, and his #1 dividend stock for a LIFETIME of income. The average price target is $5.88, with a high forecast of $6.25 and a low forecast of $5.50. Dedicated to Patients Living With Chronic Conditions. BioDelivery Sciences (BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA ) technology and other drug delivery technologies to develop Emphasis is placed on developments in handling the numerical problems associated with stable distribution (a main technical difficulty until recently). No index. Annotation copyrighted by Book News, Inc., Portland, OR Biodelivery Sciences International stock forecast,
stock price predictions may be different due to the different analyzed time series. ET by Tomi Kilgore BioDelivery upgraded to buy from neutral at Janney Montgomery Scott 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. sagarsenta_9927
BioDelivery Sciences International has only been the subject of 1 research reports in the past 90 days. The P/E ratio of BioDelivery Sciences International is 12.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 14.46. Found insideThe Handbook of the Economics of Corporate Governance, Volume One, covers all issues important to economists. stock was originally listed at a price of $3.30 in Jul 25, 2002. The BDSI stock price can go up